Glenmark Pharmaceuticals has seized the spotlight within India’s pharmaceutical landscape, propelled by a record-breaking global licensing agreement for its flagship oncology asset.
Divi's Labs and Glenmark shares jumped to 52-week highs and the stocks closed near their highs. On technical charts, both the stocks are looking strong.
Laurus Labs, Asahi India Glass, and Poonawalla Fincorp shares were among winners this week. Laurus Labs touched 52-week high at Rs 777.9 and the stock closed at Rs 777.7 (almost at its highs).